ADVENZYMES logo

Advanced Enzyme Technologies Limited Stock Price

NSEI:ADVENZYMES Community·₹37.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

ADVENZYMES Share Price Performance

₹330.80
-136.40 (-29.20%)
24.8% undervalued intrinsic discount
₹440.00
Fair Value
₹330.80
-136.40 (-29.20%)
24.8% undervalued intrinsic discount
₹440.00
Fair Value
Price ₹330.80
AnalystConsensusTarget ₹440.00

ADVENZYMES Community Narratives

AnalystConsensusTarget·Updated
Fair Value ₹440 24.8% undervalued intrinsic discount

Preventive Health And Green Chemistry Will Expand Future Markets

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent ADVENZYMES News & Updates

Preventive Health And Green Chemistry Will Expand Future Markets

Key Takeaways Expansion into health, wellness, and sustainable enzymatic solutions, along with new B2C initiatives, positions for growth and improved margins as consumer demand rises. International diversification, R&D investment, and increased capacity utilization support long-term product differentiation, earnings stability, and operating leverage.

Here's What's Concerning About Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital

Aug 04
Here's What's Concerning About Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Dividend Will Be ₹1.20

Jun 27
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Dividend Will Be ₹1.20

Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Due To Pay A Dividend Of ₹1.20

Jun 12
Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Due To Pay A Dividend Of ₹1.20

Advanced Enzyme Technologies Limited Key Details

₹6.7b

Revenue

₹1.8b

Cost of Revenue

₹4.9b

Gross Profit

₹3.5b

Other Expenses

₹1.4b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
12.24
Gross Margin
72.90%
Net Profit Margin
20.48%
Debt/Equity Ratio
2.7%

Advanced Enzyme Technologies Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet average dividend payer.

0 Risks
2 Rewards

About ADVENZYMES

Founded
1957
Employees
338
CEO
n/a
WebsiteView website
www.advancedenzymes.com

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. In contrast, the market has seen a decline of 4.7% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›